These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24103320)

  • 1. Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.
    Kruszelnicka O; Surdacki A; Golay A
    Cardiovasc Diabetol; 2013 Oct; 12():145. PubMed ID: 24103320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study.
    Surdacki A; Kruszelnicka O; Rakowski T; Jaźwińska-Kozuba A; Dubiel JS
    Cardiovasc Diabetol; 2013; 12():64. PubMed ID: 23578341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
    Lu TM; Ding YA; Charng MJ; Lin SJ
    Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of asymmetric dimethylarginine (ADMA) with extent and functional severity of coronary atherosclerosis.
    Mangiacapra F; Conte M; Demartini C; Muller O; Delrue L; Dierickx K; Di Sciascio G; Trimarco B; De Bruyne B; Wijns W; Bartunek J; Barbato E
    Int J Cardiol; 2016 Oct; 220():629-33. PubMed ID: 27391005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance.
    Surdacki A; Stochmal E; Szurkowska M; Bode-Böger SM; Martens-Lobenhoffer J; Stochmal A; Klecha A; Kawecka-Jaszcz K; Dubiel JS; Huszno B; Szybiński Z
    Metabolism; 2007 Jan; 56(1):77-86. PubMed ID: 17161229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine predicts impaired epicardial coronary vasomotion in patients with angina in the absence of obstructive coronary artery disease.
    Parikh RV; Pargaonkar V; Ball RL; Kobayashi Y; Kimura T; Yeung AC; Cooke JP; Tremmel JA
    Int J Cardiol; 2020 Jan; 299():7-11. PubMed ID: 31416658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography.
    Arbel Y; Zlotnik M; Halkin A; Havakuk O; Berliner S; Herz I; Rabinovich I; Keren G; Bazan S; Finkelstein A; Banai S
    Clin Res Cardiol; 2014 Mar; 103(3):223-7. PubMed ID: 24271460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
    Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
    Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pro 12 Ala substitution in the PPARγ2 polymorphism may decrease the number of diseased vessels and the severity of angiographic coronary artery.
    Youssef SM; Mohamed N; Afef S; Khaldoun BH; Fadoua N; Fadhel NM; Naceur SM
    Coron Artery Dis; 2013 Aug; 24(5):347-51. PubMed ID: 23652363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease.
    Granér M; Syvänne M; Kahri J; Nieminen MS; Taskinen MR
    Ann Med; 2007; 39(2):137-44. PubMed ID: 17453676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do ANGPTL-4 and galectin-3 reflect the severity of coronary artery disease?
    Goenka L; George M; Singh V; Jena A; Seshadri D; Karunakaran V; Elumalai DV; Rani J; Kaliappan I
    Ther Adv Cardiovasc Dis; 2017 Oct; 11(10):261-270. PubMed ID: 28795637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study.
    Kruszelnicka O; Świerszcz J; Bednarek J; Chyrchel B; Surdacki A; Nessler J
    Int J Mol Sci; 2016 Apr; 17(4):454. PubMed ID: 27092494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease.
    Aktoz T; Aktoz M; Tatlı E; Kaplan M; Turan FN; Barutcu A; Atakan IH; Demir M; Altun A
    Int Urol Nephrol; 2010 Dec; 42(4):873-9. PubMed ID: 20091222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between plasma asymmetrical dimethylarginine and coronary artery disease].
    Song Y; Qu XF; Yu YW; Luan TZ; Li JJ; Guo H; Yu Y
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1527-30. PubMed ID: 17785101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery calcification, ADMA, and insulin resistance in CKD patients.
    Kobayashi S; Oka M; Maesato K; Ikee R; Mano T; Hidekazu M; Ohtake T
    Clin J Am Soc Nephrol; 2008 Sep; 3(5):1289-95. PubMed ID: 18562597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of asymmetrical dimethylarginine (ADMA) and coronary artery disease in men with erectile dysfunction.
    Maas R; Wenske S; Zabel M; Ventura R; Schwedhelm E; Steenpass A; Klemm H; Noldus J; Böger RH
    Eur Urol; 2005 Dec; 48(6):1004-11; discussion 1011-2. PubMed ID: 16139418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris.
    Adamson PD; Hunter A; Madsen DM; Shah ASV; McAllister DA; Pawade TA; Williams MC; Berry C; Boon NA; Flather M; Forbes J; McLean S; Roditi G; Timmis AD; van Beek EJR; Dweck MR; Mickley H; Mills NL; Newby DE
    Circ Cardiovasc Qual Outcomes; 2018 Feb; 11(2):e004227. PubMed ID: 29444926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of electronegative low-density lipoprotein on angiographic coronary atherosclerotic burden.
    Niccoli G; Bacà M; De Spirito M; Parasassi T; Cosentino N; Greco G; Conte M; Montone RA; Arcovito G; Crea F
    Atherosclerosis; 2012 Jul; 223(1):166-70. PubMed ID: 22640815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease.
    Wolf C; Lorenzen JM; Stein S; Tsikas D; Störk S; Weidemann F; Ertl G; Anker SD; Bauersachs J; Thum T
    Int J Cardiol; 2012 May; 156(3):289-94. PubMed ID: 21159392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.